Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation

Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation

Bibliographic Details
Main Authors:	Michael Spartalis, MD, MSc, PhD, Eleni Tzatzaki, MD, PhD, Nikolaos I. Nikiteas, MD, MSc, PhD, Eleftherios Spartalis, MD, MSc, PhD
Format:	Article
Language:	English
Published:	Wiley 2017-12-01
Series:	Journal of Arrhythmia
Online Access:	http://www.sciencedirect.com/science/article/pii/S1880427617301436

Similar Items

Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran
by: Aleksandra Lenart-Migdalska MD, et al.
Published: (2020-11-01)

Surgical Ablation of Atrial Fibrillation
by: Taijiro Sueda, MD PhD
Published: (2005-01-01)

Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
by: Vanessa M. Silva PhD, et al.
Published: (2019-03-01)

Catheter Ablation of Atrial Fibrillation: Where Are We?
by: Xinqiang Han, MD, PhD, FACC, et al.
Published: (2017-02-01)

Pulmonary vein stenosis after second-generation cryoballoon ablation for atrial fibrillation
by: Kenichi Tokutake, MD, et al.
Published: (2017-01-01)

Delayed cardiac tamponade in catheter ablation for paroxysmal atrial fibrillation induced by a subacute hemorrhage
by: Hironori Ishiguchi, MD, PhD, et al.
Published: (2020-07-01)

Surgical Treatment of Chronic Atrial Fibrillation—Unipolar Radiofrequency Ablation versus Cryoablation, and Left Atrial versus Bi-atrial Maze Procedures
by: Masaharu Yoshikawa, MD PhD, et al.
Published: (2006-01-01)

Focal Pseudo-Atrial Fibrillation after Radiofrequency Ablation of Focal Atrial Tachycardia
by: Tadanobu Irie, MD, et al.
Published: (2010-01-01)

Long-Term Outcomes of Surgical Ablation for Atrial Fibrillation
by: Ho Jin Kim, MD, et al.
Published: (2021-09-01)

Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
by: Miyoko Naganuma, PhD, et al.
Published: (2017-04-01)

Inflammation and Atrial Fibrillation
by: Yasumi Endoh, MD PhD, et al.
Published: (2011-01-01)

Early experiences with three types of balloon-based ablation catheters in patients with paroxysmal atrial fibrillation
by: Atsushi Kobori, MD, PhD, et al.
Published: (2021-06-01)

Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation
by: Jichao Zhao, PhD, et al.
Published: (2015-01-01)

Massive Air Embolism During Atrial Fibrillation Ablation
by: Duc H. Do, MD, et al.
Published: (2021-01-01)

Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure
by: Hiroki Ikenaga, MD, et al.
Published: (2017-08-01)

Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
by: Fuminori Namino MT, et al.
Published: (2019-05-01)

A case of an ablation catheter entrapped in the pulmonary vein during atrial fibrillation ablation requiring open heart surgery for removal
by: Ryudo Fujiwara, MD, PhD, et al.
Published: (2017-01-01)

Machine learning enables noninvasive prediction of atrial fibrillation driver location and acute pulmonary vein ablation success using the 12-lead ECG
by: Giorgio Luongo, MSc, et al.
Published: (2021-04-01)

Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure
by: Michelle Samuel, MPH, PhD, et al.
Published: (2020-05-01)

Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
by: Yoshio Takemoto, MD, PhD, et al.
Published: (2016-04-01)

Current overview of the genetic background of atrial fibrillation: Possible therapeutic gene targets for the treatment of atrial fibrillation
by: Tetsushi Furukawa, MD, PhD, et al.
Published: (2012-06-01)

Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran
by: Yurong Xiong MM, et al.
Published: (2020-04-01)

Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience
by: Naoki Shibata, MD, et al.
Published: (2017-02-01)

Pharmacological Treatment for Atrial Fibrillation
by: Kaoru Sugi, MD PhD, et al.
Published: (2005-01-01)

Lengthening the atrioventricular delay reduces large left atrial v waves and dyspnea after atrial fibrillation and tachycardia ablation
by: Raman Mitra, MD, PhD, FHRS
Published: (2017-12-01)

Radiofrequency catheter ablation for drug-refractory paroxysmal atrial fibrillation in a patient with Ebstein’s anomaly
by: Yong-Giun Kim, MD, et al.
Published: (2017-01-01)

Atrial tachycardia caused by a superior vena cava fibrillation with conduction block
by: Masatsugu Nozoe, MD, PhD, et al.
Published: (2012-10-01)

Radiofrequency catheter ablation of a sporadically occurring ventricular arrhythmia originating from the right ventricular outflow tract: A novel arrhythmia induction strategy involving atrial fibrillation provocation
by: Taro Koya, MD, et al.
Published: (2020-07-01)

Atrial Fibrillation and Atrial Fibrillation Intervals—Frequency Analysis and Interpretation—
by: Akihiko Shimizu, MD, PhD, FACC
Published: (2005-01-01)

Clinical implications of serum adiponectin on progression of atrial fibrillation
by: Naoko Yamaguchi, MD, PhD, et al.
Published: (2017-12-01)

Successful ablation for non-pulmonary multi-foci atrial fibrillation/tachycardia in a patient with coronary sinus ostial atresia by transseptal puncture and epicardial approach
by: Yukihiro Inamura, MD, et al.
Published: (2017-05-01)

Clinical benefits of deep sedation with a supraglottic airway while monitoring the bispectral index during catheter ablation of atrial fibrillation
by: Satoru Hida, M.D., et al.
Published: (2017-08-01)

Peri–coronary sinus atrial flutter associated with prior slow pathway ablation
by: Mitsunori Maruyama, MD, PhD, FHRS, et al.
Published: (2018-01-01)

The feasibility of a Box isolation strategy for non-paroxysmal atrial fibrillation in elderly patients
by: Satoshi Higuchi, MD, et al.
Published: (2016-06-01)

Biphasic P wave in inferior leads and the development of atrial fibrillation
by: Hideki Hayashi, MD, PhD, et al.
Published: (2015-12-01)

The usefulness of nifekalant for activation mapping of premature beat-triggered atrial fibrillation: Suppression of atrial fibrillation initiation without inhibiting premature beat
by: Masaharu Masuda, MD, et al.
Published: (2014-12-01)

An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter
by: Roopinder K. Sandhu, MD, MPH, et al.
Published: (2019-07-01)

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
by: Hugh Calkins, MD, et al.
Published: (2017-10-01)

The presence of left atrial posterior wall fibrillation despite restoration of sinus rhythm after posterior box ablation
by: Khalid Abozguia, MD, PhD, et al.
Published: (2015-11-01)

Atrial fibrillation ablation–induced gastroparesis: A case report and literature review
by: Tauseef Akhtar, MD, et al.
Published: (2020-05-01)

Cannot write session to /tmp/vufind_sessions/sess_vhpm339ch6sio7kepsketsr9hl